Blood clots are a fairly common and potentially fatal complication of heart disease in cats. In human medicine, acute blood clots can often be managed effectively with thrombolysis therapy, or “clot busting.” In this clinical trial study, researchers will investigate the effectiveness of thrombolysis therapy in client-owned cats with heart disease and a recent acute blood clot. Results from this study could reduce mortality and improve quality of life of cats with blood clots associated with severe heart disease.
Study ID
D15FE-304
Study Status
Complete
Start Date
11/01/2014
Grant amount awarded
$95,878
Grant recipient
The Ohio State University
Study country
United States
Investigator
Julien Guillaumin, DVM
Study category
Cardiovascular
Publications